Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.4058 | 0.4058 |
Giardia lamblia | Kinase, PLK | 0.0092 | 1 | 0.5 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0092 | 1 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.8016 | 0.8016 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0092 | 1 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.4058 | 0.4058 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.4058 | 0.4058 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0092 | 1 | 1 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0092 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.4058 | 0.4058 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.4058 | 0.4058 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.8016 | 0.8016 |
Schistosoma mansoni | kinase | 0.0047 | 0.4334 | 0.4334 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 1 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0092 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 1 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.0092 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.8016 | 0.8016 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0092 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.8016 | 0.8016 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.8016 | 0.8016 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.8016 | 0.8016 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 1 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.8016 | 0.8016 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.4058 | 0.4058 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.8016 | 0.8016 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.4058 | 0.4058 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0092 | 1 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.8016 | 0.8016 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0092 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.8016 | 0.8016 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.8016 | 0.8016 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.4058 | 0.4058 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0092 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.8016 | 0.8016 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.4058 | 0.4058 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.8016 | 0.8016 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.1623 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (binding) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375] | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.